Curepharma
ActiveSummary
Curepharma has been active since 1983 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €355,161 and a net result of -€63,131. Equity is growing by about 5.2% per year across the filed financial years. Its solvency ranks better than 81% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Curepharma
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Indien de vennootschap door meer dan één bestuurder wordt bestuurd, mag iedere bestuurder, alleen optredend, alle handelingen stellen die…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Één of meer bestuurders, bestuursorgaan” (deed in Dutch)“Vergoeding bestuurders, algemene vergadering beslist of mandaat al dan niet ten kosteloze titel” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- First Friday of May at 11:00